Data Diagnostics Wins Gold at the 30th Annual Edison Awards
Healthcare analytics technology from Quest Diagnostics and Inovalon turns patient data into actionable insights that inform quality, reimbursement and care outcomes
MADISON, N.J. – April 24, 2017 – Quest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) announced that Data Diagnostics®, a point-of-care health analytics technology, won a gold award in the Health and Wellness—Patient Care category at the 2017 Edison Awards, which honor the best innovations and innovators internationally. Data Diagnostics®, offered jointly by Quest Diagnostics and Inovalon, is a healthcare analytics technology that provides patient-specific reports to the physician in the electronic health record (EHR) to help support clinical actions that directly affect care quality, patient outcomes and reimbursement. The offering is part of the Quest Diagnostics Quanum™ suite of healthcare information and technology solutions.
“The Edison Awards honor innovations that make an impact, and it is therefore gratifying to see Data Diagnostics' potential impact on healthcare be recognized with this honor,” said David Freeman, general manager, Information Ventures, Quest Diagnostics. “Data Diagnostics® pulls together near real-time patient insights from multi-sourced data. The analytics highlight gaps in care relative to evidence-based quality guidelines via the physician’s EHR for use at the point of care. It's a solution that supports efficient improvements in patient care, while helping the physician and health plan reach financial goals due to quality-based incentives.”
“Inovalon is highly focused on delivering innovative technologies for the healthcare industry,” said Kris Volrath, associate vice president and general manager, Inovalon. “Data Diagnostics® brings the power of advanced analytics to the healthcare ecosystem in real-time, helping physicians to treat their patients more effectively at the point of care driving meaningful impact and value that will further drive the transformation of healthcare as we know it.”
Since 1987, the Edison Awards have recognized and honored some of the most innovative new products, services and business leaders in America. More than 400 nominations from around the world were reviewed by 3,000 senior business executives from the fields of product development, engineering, science, marketing and education.
About Data Diagnostics®
Data Diagnostics®, a joint solution offered by Quest Diagnostics and Inovalon, is a point-of-care health analytics technology that produces patient-specific reports in real time to help physicians easily identify and address gaps in quality, risk, utilization and medical history. Reports draw from information in the physician’s EHR as well as data from Quest’s 20 billion clinical laboratory test results and Inovalon’s clinical datasets on more than 150 million Americans. Physicians can order Data Diagnostics® reports within their existing workflow and EHR, receiving an easy-to-read actionable report, often within seconds. Data Diagnostics® is designed to be used with the practice’s existing technology and workflows with minimal training.
Data Diagnostics® has won several industry awards, including the Best in Biz Most Innovative Product of the Year for Healthcare and a Gold Edison Award for Health and Wellness—Patient Care. Data Diagnostics® is part of the Quest Diagnostics Quanum™ suite of healthcare information and technology solutions. www.QuestDiagnostics.com/DataDiagnostics
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 43,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com
50th Anniversary: In 2017, Quest Diagnostics celebrates 50 years of life-changing results. To learn about our legacy of accomplishments and quest to improve healthcare in the future, visit www.QuestDiagnostics.com/50Years.
Inovalon is a leading technology company providing cloud-based platforms empowering a data-driven transformation from volume-based to value-based models throughout the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and industry-leading subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon's unique achievement of value is delivered through the effective progression of "Turning Data into Insight, and Insight into Action®." Providing technology that supports nearly 500 healthcare organizations, Inovalon's platforms are informed by data pertaining to more than 848,000 physicians, 371,000 clinical facilities, and more than 150 million Americans. For more information, visit www.inovalon.com or www.datadiagnostics.com.
Kim E. Collins (Media): 301-809-4000 x1473
George Price (Investors): 301-809-4000 x1190
Rachel Robbins, Greenough (Media): 617-275-6521 or email@example.com
Wendy Bost, Quest Diagnostics (Media): 973-520-2800
Shawn Bevec, Quest Diagnostics (Investors): 973-520-2900